Evidence map›Paper›PMID 31940988›Full record

ArticleMicroorganisms2020

Rapid Detection of Echinocandins Resistance by MALDI-TOF MS in

Ana Emília M Roberto, Danilo E Xavier, Esteban E Vidal, Cláudia Fernanda de L Vidal, Rejane P Neves, Reginaldo G de Lima-Neto

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Optimizing MALDI-TOF MS for routine dermatophyte identification, including Trichophyton indotineae.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. [Rapid detection of fluconazole resistance inNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Isavuconazole activity againstFuture microbiology · 2025
    Article
  8. Article
  9. Article
  10. Global Prevalence of Antifungal-ResistantTropical medicine and infectious disease · 2022
    Review
  11. Diagnosis and Treatment of Invasive Candidiasis.Antibiotics (Basel, Switzerland) · 2022
    Review
  12. Review
  13. Review
  14. Review
  15. Are We Ready for NosocomialFrontiers in cellular and infection microbiology · 2021
    Article
  16. Can We Improve Antifungal Susceptibility Testing?Frontiers in cellular and infection microbiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Ana Emília M RobertoGraduate Program in Fungal Biology, Federal University of Pernambuco (UFPE), Recife-PE 50.740-600, Brazil.
Danilo E XavierInstituto Aggeu Magalhães, FIOCRUZ, Recife-PE 50.670-420, Brazil.ORCID 0000-0002-4242-2063
Esteban E VidalCenter for Strategic Technologies Northeastern (CETENE), Recife-PE 50.740-545, Brazil.
Cláudia Fernanda de L VidalHospital of Clinics, Recife-PE 50.670-901, Brazil.
Rejane P NevesGraduate Program in Fungal Biology, Federal University of Pernambuco (UFPE), Recife-PE 50.740-600, Brazil.
Reginaldo G de Lima-NetoGraduate Program in Fungal Biology, Federal University of Pernambuco (UFPE), Recife-PE 50.740-600, Brazil.
Universidade Federal de Pernambuco · BRCentro de Tecnologias Estratégicas do Nordeste · BRFundação Oswaldo Cruz · BRHospital das Clínicas da Universidade Federal de Pernambuco · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 315416/2018-1Conselho Nacional de Desenvolvimento Científico e Tecnológico 455745/2014-5
6 · The paper itself

Abstract

Mass spectrometry by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) was used to identify and differentiate the pattern of susceptibility of clinical isolates of

Indexed as

candidemiamass spectrometryresistancesusceptibility testing

Identifiers

PMID31940988
PMCPMC7023175
OpenAlexW2999188309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.